Xiaofeng Chen

Area of research

Pulmonary and Respiratory Medicine · Oncology

Research interest

Research focused on Antigen and Sorafenib, with related work in Immunology, Urination, Hepatocellular carcinoma. Notable publications include 'Upregulation of bacterial-specific Th1 and Th17 responses that are enriched in CXCR5 + CD4 + T cells in non-small cell lung cancer', 'Diagnosis and management of urinary bladder paragangliomas: A Sino‐American‐European retrospective observational study', and 'Phosphorylated FOXQ1, a novel substrate of JNK1, inhibits sorafenib-induced ferroptosis by activating ETHE1 in hepatocellular carcinoma'.

h-index

—

citations

works

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

Diagnosis and management of urinary bladder paragangliomas: A Sino‐American‐European retrospective observational study

Clinical Endocrinology 2024cited by 12position: middledoi

Phosphorylated FOXQ1, a novel substrate of JNK1, inhibits sorafenib-induced ferroptosis by activating ETHE1 in hepatocellular carcinoma

Cell Death and Disease 2024cited by 9position: middledoi

Upregulation of bacterial-specific Th1 and Th17 responses that are enriched in CXCR5 + CD4 + T cells in non-small cell lung cancer

International Immunopharmacology 2017cited by 35position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Pulmonary and Respiratory Medicine · Oncology →